# Randomized Controlled Trial of Gemcitabine Combined With 125I Brachytherapy

> **NCT00644618** · PHASE3 · COMPLETED · sponsor: **Huazhong University of Science and Technology** · enrollment: 120 (actual)

## Conditions studied

- Locally Advanced Pancreatic Cancer

## Interventions

- **DRUG:** gemcitabine
- **OTHER:** 125I brachytherapy PLUS gemcitabine

## Key facts

- **NCT ID:** NCT00644618
- **Lead sponsor:** Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** 2007-12
- **Final completion:** 2008-01
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2008-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00644618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00644618, "Randomized Controlled Trial of Gemcitabine Combined With 125I Brachytherapy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00644618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*